- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
EQL Pharma AB (EQL)
EQL Pharma AB stock price live, this page displays ST EQL stock exchange data. View the EQL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the EQL Pharma AB real time stock price chart below.
What Is the EQL Pharma AB Stock Price Today?
The EQL Pharma AB stock price today is 60.3000.
What Is the Stock Symbol for EQL Pharma AB?
The stock symbol for EQL Pharma AB is ""EQL.""
What Stock Exchange Does EQL Pharma AB Trade On?
EQL Pharma AB is listed and trades on the Stockholm stock exchange.
Is EQL Pharma AB a Good Stock to Buy?
Determining whether EQL Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EQL quote. (ISIN: SE0005497732)
What Is the EQL Pharma AB Stock Price Today?
The EQL Pharma AB stock price today is 60.3000.
What Is the Stock Symbol for EQL Pharma AB?
The stock symbol for EQL Pharma AB is ""EQL.""
What Stock Exchange Does EQL Pharma AB Trade On?
EQL Pharma AB is listed and trades on the Stockholm stock exchange.
Is EQL Pharma AB a Good Stock to Buy?
Determining whether EQL Pharma AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EQL quote. (ISIN: SE0005497732)
Stockholm
Currency in SEK
60.3000
-0.4000(-0.66%)
Closed·
Fair Value
An estimate of a EQL Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.0000
60.5000
52 wk Range
46.5500
98.6000
EQL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a EQL Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
59.000060.5000
52 wk Range
46.550098.6000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EQL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a EQL Pharma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
EQL Pharma AB Company Profile
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL Pharma AB (publ) was incorporated in 2006 and is based in Lund, Sweden.
EQL Pharma AB Earnings Call Summary for Q2/2026
- EQL Pharma reported modest 1% sales growth in Q2 2025, with gross margin falling to 38% and EBITDA margin at 10% due to supply chain disruptions.
- The company adjusted its growth outlook to 15% for 2025-2026, expecting an EBITDA margin around 20% for the full year, with cash position at SEK 78 million.
- Strategic expansion plans include launching 100 niche products in Germany and the Netherlands by 2028-2029, with the first special generics product expected between 2026-2027.
- Melosan received approval in Turkey, with a UK launch planned through partner Medisa as part of the company's international market expansion strategy.
Last Updated: 05/11/2025, 10:48
Read Full TranscriptCompare EQL to Peers and Sector
Metrics to compare | EQL | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipEQLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 60.1x | 76.0x | −0.6x | |
PEG Ratio | −7.85 | 0.22 | 0.00 | |
Price/Book | 6.8x | 3.0x | 2.6x | |
Price / LTM Sales | 4.5x | 1.4x | 3.4x | |
Upside (Analyst Target) | 32.7% | 18.2% | 44.8% | |
Fair Value Upside | Unlock | 9.2% | 6.6% | Unlock |
Earnings
Latest Release
Nov 07, 2025
EPS / Forecast
-0.11 / 0.45
Revenue / Forecast
86.20M / 115.35M
People Also Watch
FAQ
What Stock Exchange Does EQL Pharma Trade On?
EQL Pharma is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for EQL Pharma?
The stock symbol for EQL Pharma is "EQL."
What Is the EQL Pharma Market Cap?
As of today, EQL Pharma market cap is 1.78B.
What Is EQL Pharma's Earnings Per Share (TTM)?
The EQL Pharma EPS (TTM) is 0.98.
When Is the Next EQL Pharma Earnings Date?
EQL Pharma will release its next earnings report on 02 Feb 2026.
From a Technical Analysis Perspective, Is EQL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has EQL Pharma Stock Split?
EQL Pharma has split 0 times.
How Many Employees Does EQL Pharma Have?
EQL Pharma has 22 employees.
What is the current trading status of EQL Pharma (EQL)?
As of 01 Feb 2026, EQL Pharma (EQL) is trading at a price of 60.3000, with a previous close of 57.0000. The stock has fluctuated within a day range of 59.0000 to 60.5000, while its 52-week range spans from 46.5500 to 98.6000.
What Is EQL Pharma (EQL) Price Target According to Analysts?
The average 12-month price target for EQL Pharma is SEK80.0000, with a high estimate of SEK80 and a low estimate of SEK80. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +32.67% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.